SCHEMBL7932899

SCHEMBL7932899

CCCN(CCC)C1CCc2cccc(C(N)=O)c2C1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 3/20 0.67
HTR7 P34969 3/20 0.67
DRD2 P14416 2/20 0.67
HTR1D P28221 2/20 0.67
DRD3 P35462 2/20 0.67
CYP1A2 P05177 1/20 0.67
CYP2D6 P10635 1/20 0.67
TSHR P16473 1/20 0.67
HTR1B P28222 1/20 0.67
HTR2A P28223 1/20 0.67
HTR2C P28335 1/20 0.67
ADRA1A P35348 1/20 0.67
ADRA1B P35368 1/20 0.67
HTR2B P41595 1/20 0.67
HTR5A P47898 1/20 0.67
BLM P54132 1/20 0.65
ALDH1A1 P00352 1/20 0.65
LMNA P02545 1/20 0.65
PMP22 Q01453 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8904245 0.90 HTR1A (0.70) HTR1AHTR7DRD2HTR1DDRD3
Hydrochloric Acid SCHEMBL8904219 0.89 HTR1A (0.68) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL7763436 0.89 HTR1A (0.68) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL7768095 0.88 HTR1A (0.67) HTR1AHTR7DRD2HTR1DDRD3
Hydrochloric Acid SCHEMBL8822572 0.88 HTR1A (0.67) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL7763446 0.88 HTR1A (0.67) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL7768660 0.86 HTR1A (0.65) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL8822668 0.85 HTR1A (0.64) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL7763400 0.85 HTR1A (0.64) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL8822628 0.85 HTR1A (0.64) HTR1AHTR7DRD2HTR1DDRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6331636-B1 TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, DIABETES, HYPERTENSION, IMPOTENCY, APPETITE CONTROL THE UPJOHN COMPANY 2001-12-18 US disclosed
US-5545755-A USEFUL TO TREAT CENTRAL NERVOUS SYSTEM DISORDERS, HYPERTENSION, DIABETES, SEXUAL IMPOTENCY AND TO CONTROL APPETITE THE UPJOHN COMPANY (US) 1996-08-13 US disclosed
EP-0476016-A1 THERAPEUTICALLY USEFUL 2-AMINOTETRALIN DERIVATIVES PHARMACIA & UPJOHN COMPANY (US) 1992-03-25 EP disclosed
US-5047422-A Treating A Disorder Of The Central Nervous System, Cardiovascular System Or Intestinal Tract BAYER AKTIENGESELLSCHAFT (DE) 1991-09-10 US disclosed
WO-1990015047-A1 THERAPEUTICALLY USEFUL 2-AMINOTETRALIN DERIVATIVES THE UPJOHN COMPANY (US) 1990-12-13 WO disclosed
US-4968679-A DISORDERS OF CENTRAL NERVOUS SYSTEM, CARDIOVASCULAR SYSTEM OR INTESTINAL TRACT BAYER AKTIENGESELLSCHAFT (DE) 1990-11-06 US disclosed
US-4873262-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, CARDIIOVASCULAR SYSTEM OR INTESTINAL TRACT BAYER AKTIENGESELLSCHAFT (DE) 1989-10-10 US disclosed
EP-0272534-A2 8-substituted 2-aminotetralins BAYER AG (DE) 1988-06-29 EP disclosed